# HomeTrust Bancshares, Inc.: financial statements, quarterly

HTB · NYSE · CIK 1538263 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/htb.md) · [Financials](/companies/htb/financials.md) · [Filings](/companies/htb/filings.md) · [Insiders](/companies/htb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/htb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q1 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [19.7](/filings/0001538263-24-000105.md) | [20.9 d](/filings/0001538263-24-000029.md) | [22.1](/filings/0001538263-24-000043.md) | [23.2](/filings/0001538263-24-000087.md) | [24.6](/filings/0001538263-24-000105.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.8](/filings/0001538263-24-000105.md) | [3.6 d](/filings/0001538263-26-000030.md) | [3.9](/filings/0001538263-25-000064.md) | [3.4](/filings/0001538263-25-000100.md) | [3.7](/filings/0001538263-25-000116.md) | [4.1 d](/filings/0001538263-26-000030.md) | [3.9](/filings/0001538263-26-000046.md) | [4.6](/filings/0001538263-26-000103.md) | [4.4](/filings/0001538263-25-000116.md) | [3.7 d](/filings/0001538263-26-000030.md) | [4.2](/filings/0001538263-26-000046.md) | [4.0](/filings/0001538263-26-000103.md) |
| Net income | $m | [14.8](/filings/0001538263-24-000105.md) | [13.5 d](/filings/0001538263-26-000030.md) | [15.1](/filings/0001538263-25-000064.md) | [12.4](/filings/0001538263-25-000100.md) | [13.1](/filings/0001538263-25-000116.md) | [14.2 d](/filings/0001538263-26-000030.md) | [14.5](/filings/0001538263-26-000046.md) | [17.2](/filings/0001538263-26-000103.md) | [16.5](/filings/0001538263-25-000116.md) | [16.1 d](/filings/0001538263-26-000030.md) | [16.8](/filings/0001538263-26-000046.md) | [15.6](/filings/0001538263-26-000103.md) |
| Diluted EPS | $ per share | [0.88](/filings/0001538263-24-000105.md) | not reported | [0.88](/filings/0001538263-25-000064.md) | [0.73](/filings/0001538263-25-000100.md) | [0.76](/filings/0001538263-25-000116.md) | not reported | [0.84](/filings/0001538263-26-000046.md) | [1.00](/filings/0001538263-26-000103.md) | [0.95](/filings/0001538263-25-000116.md) | not reported | [0.99](/filings/0001538263-26-000046.md) | [0.94](/filings/0001538263-26-000103.md) |
| Basic EPS | $ per share | [0.88](/filings/0001538263-24-000105.md) | not reported | [0.88](/filings/0001538263-25-000064.md) | [0.73](/filings/0001538263-25-000100.md) | [0.77](/filings/0001538263-25-000116.md) | not reported | [0.84](/filings/0001538263-26-000046.md) | [1.01](/filings/0001538263-26-000103.md) | [0.96](/filings/0001538263-25-000116.md) | not reported | [1.00](/filings/0001538263-26-000046.md) | [0.95](/filings/0001538263-26-000103.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q1 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [325](/filings/0001538263-23-000056.md) | [347](/filings/0001538263-25-000040.md) | [380](/filings/0001538263-24-000043.md) | [294](/filings/0001538263-24-000087.md) | [293](/filings/0001538263-24-000105.md) | [279](/filings/0001538263-26-000030.md) | [300](/filings/0001538263-25-000064.md) | [297](/filings/0001538263-25-000100.md) | [316](/filings/0001538263-25-000116.md) | [325](/filings/0001538263-26-000103.md) | [301](/filings/0001538263-26-000046.md) | [273](/filings/0001538263-26-000103.md) |
| Total assets | $m | [4,652](/filings/0001538263-23-000056.md) | [4,673](/filings/0001538263-25-000040.md) | [4,684](/filings/0001538263-24-000043.md) | [4,671](/filings/0001538263-24-000087.md) | [4,637](/filings/0001538263-24-000105.md) | [4,595](/filings/0001538263-26-000030.md) | [4,558](/filings/0001538263-25-000064.md) | [4,578](/filings/0001538263-25-000100.md) | [4,592](/filings/0001538263-25-000116.md) | [4,546](/filings/0001538263-26-000103.md) | [4,386](/filings/0001538263-26-000046.md) | [4,440](/filings/0001538263-26-000103.md) |
| Total liabilities | $m | [4,168](/filings/0001538263-23-000056.md) | [4,173](/filings/0001538263-25-000040.md) | [4,171](/filings/0001538263-24-000043.md) | [4,147](/filings/0001538263-24-000087.md) | [4,097](/filings/0001538263-24-000105.md) | [4,044](/filings/0001538263-26-000030.md) | [3,993](/filings/0001538263-25-000064.md) | [3,999](/filings/0001538263-25-000100.md) | [3,996](/filings/0001538263-25-000116.md) | [3,945](/filings/0001538263-26-000103.md) | [3,794](/filings/0001538263-26-000046.md) | [3,840](/filings/0001538263-26-000103.md) |
| Shareholders' equity | $m | [484](/filings/0001538263-23-000056.md) | [500](/filings/0001538263-25-000040.md) | [513](/filings/0001538263-24-000043.md) | [524](/filings/0001538263-24-000087.md) | [540](/filings/0001538263-24-000105.md) | [552](/filings/0001538263-26-000030.md) | [565](/filings/0001538263-25-000064.md) | [579](/filings/0001538263-25-000100.md) | [596](/filings/0001538263-25-000116.md) | [601](/filings/0001538263-26-000103.md) | [592](/filings/0001538263-26-000046.md) | [601](/filings/0001538263-26-000103.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(33.0)](/filings/0001538263-23-000056.md) | [28.4 d](/filings/0001538263-26-000030.md) | [(9.0)](/filings/0001538263-25-000064.md) | [5.9 d](/filings/0001538263-25-000100.md) | [43.8 d](/filings/0001538263-25-000116.md) | [4.8 d](/filings/0001538263-26-000030.md) | [71.7](/filings/0001538263-26-000046.md) | [(8.6) d](/filings/0001538263-26-000103.md) | [(11.5) d](/filings/0001538263-25-000116.md) | [(2.1) d](/filings/0001538263-26-000030.md) | [111](/filings/0001538263-26-000046.md) | [1.5 d](/filings/0001538263-26-000103.md) |
| Capital expenditure | $m | [0.3](/filings/0001538263-23-000056.md) | [0.2 d](/filings/0001538263-26-000030.md) | [0.6](/filings/0001538263-25-000064.md) | [0.2 d](/filings/0001538263-25-000100.md) | [0.7 d](/filings/0001538263-25-000116.md) | [1.5 d](/filings/0001538263-26-000030.md) | [1.0](/filings/0001538263-26-000046.md) | [1.3 d](/filings/0001538263-26-000103.md) | [0.8 d](/filings/0001538263-25-000116.md) | [1.0 d](/filings/0001538263-26-000030.md) | [0.8](/filings/0001538263-26-000046.md) | [1.3 d](/filings/0001538263-26-000103.md) |
| Dividends paid | $m | [1.7](/filings/0001538263-23-000056.md) | [1.9 d](/filings/0001538263-26-000030.md) | [1.9](/filings/0001538263-25-000064.md) | [1.9 d](/filings/0001538263-25-000100.md) | [1.9 d](/filings/0001538263-25-000116.md) | [2.1 d](/filings/0001538263-26-000030.md) | [2.1](/filings/0001538263-26-000046.md) | [2.1 d](/filings/0001538263-26-000103.md) | [2.1 d](/filings/0001538263-25-000116.md) | [2.2 d](/filings/0001538263-26-000030.md) | [2.2](/filings/0001538263-26-000046.md) | [2.5 d](/filings/0001538263-26-000103.md) |
| Share repurchases | $m | [0.0 d](/filings/0001538263-24-000105.md) | [0.0 d](/filings/0001538263-26-000030.md) | [0.0](/filings/0001538263-25-000064.md) | [0.6 d](/filings/0001538263-25-000100.md) | [0.0 d](/filings/0001538263-25-000116.md) | [0.0 d](/filings/0001538263-26-000030.md) | [0.5](/filings/0001538263-26-000046.md) | [2.8 d](/filings/0001538263-26-000103.md) | [0.0 d](/filings/0001538263-25-000116.md) | [10.3 d](/filings/0001538263-26-000030.md) | [23.1](/filings/0001538263-26-000046.md) | [7.2 d](/filings/0001538263-26-000103.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q1 FY2024 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q1 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.2](/filings/0001538263-23-000009.md) | [16.1](/filings/0001538263-24-000043.md) | [16.8](/filings/0001538263-24-000087.md) | [16.8](/filings/0001538263-24-000105.md) | [16.9](/filings/0001538263-25-000064.md) | [16.9](/filings/0001538263-25-000100.md) | [17.0](/filings/0001538263-25-000116.md) | [17.1](/filings/0001538263-26-000046.md) | [17.1](/filings/0001538263-26-000103.md) | [17.1](/filings/0001538263-25-000116.md) | [16.7](/filings/0001538263-26-000046.md) | [16.4](/filings/0001538263-26-000103.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,693,180 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001538263-26-000103.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.